Scalper1 News
French pharmaceutical giant Sanofi (SNY) suffered two analyst downgrades Monday morning after its investor day Friday failed to reassure Wall Street of its longer-term prospects. New CEO Olivier Brandicourt laid out a “roadmap for long-term growth,” predicting 3% to 4% compound annual growth through 2020, with EPS growing faster than sales after 2018. Sanofi will focus on diabetes (touting its collaboration with Alphabet’s (GOOGL) Google Life Scalper1 News
Scalper1 News